Literature DB >> 17550567

Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report.

Felipe Francisco Tuon1, Valdir Sabbaga Amato, Lucile Maria Floeter-Winter, Ricardo de Andrade Zampieri, Vicente Amato Neto, Francisco Oscar Siqueira França, Maria Aparecida Shikanai-Yasuda.   

Abstract

American tegumentary leishmaniasis (ATL), an endemic anthropozoonosis in various countries in the world, is caused by parasites of the genus Leishmania. Despite reports on ATL reactivation as a result of immunosuppression, to the best of our knowledge, this paper describes the first case of ATL reactivation in its localized form (cutaneous leishmaniasis) associated with the administration of systemic corticosteroids. The possible action of corticosteroids on the host immune response to the parasite in patients with localized cutaneous leishmaniasis is discussed. This report demonstrates the possibility of ATL reactivation in patients using corticosteroids, an observation that should be considered in individuals treated with this medication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550567     DOI: 10.1111/j.1365-4632.2006.03096.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  15 in total

Review 1.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

2.  Alteration of Direct Agglutination Test (DAT) results in Iranian Kala-Azar patients: a case series.

Authors:  Soheila Molaie; Mehdi Mohebali; Mohamad-Reza Abai; Akbar Molaie; Behnaz Akhoundi; Eslam Moradi Asl
Journal:  J Parasit Dis       Date:  2016-08-31

3.  A rare cause of postinfectious glomerulonephritis: Answers.

Authors:  Ozlem Yuksel Aksoy; Adem Yasin Koksoy; Saba Kiremitci; Nilgun Cakar; Fatma Semsa Cayci
Journal:  Pediatr Nephrol       Date:  2020-06-25       Impact factor: 3.714

4.  Progressive Perforation of the Nasal Septum Due to Leishmania major: A Case of Mucosal Leishmaniasis in a Traveler.

Authors:  Nicole Harrison; Julia Walochnik; Reinhard Ramsebner; Luzia Veletzky; Heimo Lagler; Michael Ramharter
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 5.  Permissive and protective roles for neutrophils in leishmaniasis.

Authors:  E D Carlsen; Y Liang; T R Shelite; D H Walker; P C Melby; L Soong
Journal:  Clin Exp Immunol       Date:  2015-08-28       Impact factor: 4.330

6.  Case Reports: Late Emergence of Cutaneous Leishmaniasis in an Immunocompromised Patient in a Non-Endemic Setting.

Authors:  David New; Benjamin A Rogers
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

7.  Case Report: Mucocutaneous Leishmaniasis Masquerading as Idiopathic Midline Granulomatous Disease.

Authors:  Nilesh Tejura; Eunjung Kim; Lisa L Dever; Debra Chew
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

8.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

Review 9.  [Common tropical infections with protozoans, worms and ectoparasites].

Authors:  S Schliemann
Journal:  Hautarzt       Date:  2014-10       Impact factor: 0.751

10.  Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.

Authors:  Felipe F Tuon; Giovana Marina Bombonatto; Eveline Roesler Battaglin; Marcus Henrique Sakumoto; Valdir Sabbaga Amato; Raphael Abegão de Camargo; Antônio Carlos Nicodemo
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.